Luxembourg is to invest €140 million over five years in a bid to become a centre of excellence in molecular medicine, partnering with three leading US institutions to help achieve the aim.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.